CUSIP 501575104 · who reports it, how much, and how much it matters to them
29 of the 720 hedge fund managers we track reported shares of Kymera Therapeutics, Inc. (Nasdaq: KYMR) on Form 13F for 30 June 2026. Between them they reported USD 2.3bn. The largest position belongs to Baker Bros. Advisors, at USD 993m. The manager with the most riding on it is Avoro Capital Advisors, where it is 7.7% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Baker Bros. Advisors2 funds on PPLI.com | USD 993m | 5.0% |
| 2 | Avoro Capital Advisors1 fund on PPLI.com | USD 857m | 7.7% |
| 3 | Holocene Advisors2 funds on PPLI.com | USD 73m | 0.2% |
| 4 | Rock Springs Capital Management2 funds on PPLI.com | USD 52m | 2.5% |
| 5 | Boxer Capital Management1 fund on PPLI.com | USD 49m | 3.7% |
| 6 | Braidwell12 funds on PPLI.com | USD 43m | 1.6% |
| 7 | Two Sigma Investments35 funds on PPLI.com | USD 43m | 0.0% |
| 8 | Octagon Capital Advisors1 fund on PPLI.com | USD 36m | 3.2% |
| 9 | RTW Investments2 funds on PPLI.com | USD 28m | 0.2% |
| 10 | Polar Capital LLP26 funds on PPLI.com | USD 23m | 0.1% |
| 11 | Adage Capital Management1 fund on PPLI.com | USD 23m | 0.0% |
| 12 | Marshall Wace LLP84 funds on PPLI.com | USD 19m | 0.0% |
| 13 | Eagle Health Investments1 fund on PPLI.com | USD 19m | 3.2% |
| 14 | Boone Capital Management1 fund on PPLI.com | USD 13m | 3.0% |
| 15 | Citadel Advisors32 funds on PPLI.com | USD 13m | 0.0% |
| 16 | Armistice Capital1 fund on PPLI.com | USD 12m | 0.1% |
| 17 | Atika Capital Management3 funds on PPLI.com | USD 12m | 0.8% |
| 18 | Squarepoint Ops7 funds on PPLI.com | USD 11m | 0.0% |
| 19 | Burkehill Global Management5 funds on PPLI.com | USD 8.6m | 0.3% |
| 20 | Yiheng Capital Management1 fund on PPLI.com | USD 7.3m | 2.5% |
| 21 | Dafna Capital Management6 funds on PPLI.com | USD 3.1m | 0.6% |
| 22 | Freestone Grove Partners1 fund on PPLI.com | USD 2.4m | 0.0% |
| 23 | Scientech Research2 funds on PPLI.com | USD 1.5m | 1.2% |
| 24 | Brandywine Managers47 funds on PPLI.com | USD 868,000 | 0.4% |
| 25 | HighVista Strategies27 funds on PPLI.com | USD 428,000 | 0.1% |
| 26 | D. E. Shaw & Co.15 funds on PPLI.com | USD 321,000 | 0.0% |
| 27 | CIBC Asset Management69 funds on PPLI.com | USD 289,000 | 0.0% |
| 28 | Bayforest Capital1 fund on PPLI.com | USD 108,000 | 0.1% |
| 29 | The Quarry1 fund on PPLI.com | USD 1,032 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Avoro Capital Advisors | USD 857m | 7.7% |
| 2 | Baker Bros. Advisors | USD 993m | 5.0% |
| 3 | Boxer Capital Management | USD 49m | 3.7% |
| 4 | Octagon Capital Advisors | USD 36m | 3.2% |
| 5 | Eagle Health Investments | USD 19m | 3.2% |
| 6 | Boone Capital Management | USD 13m | 3.0% |
| 7 | Rock Springs Capital Management | USD 52m | 2.5% |
| 8 | Yiheng Capital Management | USD 7.3m | 2.5% |
| 9 | Braidwell | USD 43m | 1.6% |
| 10 | Scientech Research | USD 1.5m | 1.2% |
Kymera Therapeutics, Inc. trades under the symbol KYMR on the Nasdaq. Its CUSIP, the code used on Form 13F, is 501575104.
29 of the 720 hedge fund managers PPLI.com tracks reported Kymera Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Baker Bros. Advisors (USD 993m), Avoro Capital Advisors (USD 857m), Holocene Advisors (USD 73m), Rock Springs Capital Management (USD 52m) and Boxer Capital Management (USD 49m).
29 managers in our coverage reported it, and between them they run 389 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Avoro Capital Advisors, where the position was 7.7% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Kymera Therapeutics, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.